ClinicalTrials.gov
public full text
Public Domain
A Phase 1 Clinical Study of CU-20401 in Chinese Healthy Population
This is an open-label, Part I/2/3/4 Phase 1 clinical study to evaluate the safety, tolerability, pharmacokinetics, and immunogenicity of a single subcutaneous injection of CU-20401 in healthy Chinese population, and to recommend an appropriate dose for subsequent clinical studies.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Copper Histidinate Treatment for Menkes Disease#873433
- A Registry Study on Shenqifuzheng（a Chinese Medicine Injection）Used in Hospitals in China#842968
- Tuberculosis in China#1008576
- A Phase I Study of GZR18 Injection in Healthy Subjects#1171289
- Evaluation and Treatment of Copper/Zinc Imbalance in Children With Autism#868835
Record · ID 830021
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive